Ertugliflozin Pidolate

Records for this ingredient, by country (identity only).

ATC — · 1 markets · 8 records

Ertugliflozin Pidolate 1 markets · 8 records Forms
Filters
MarketUS 8
Kind

US 8 records · 7 shown of 8 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

  • 15 mgtablet CombinationErtugliflozin Pidolate 15 mg + Sitagliptin 100 mgSTEGLUJAN
  • 7.5 mgtablet CombinationErtugliflozin Pidolate 7.5 mg + Metformin 1,000 mgSEGLUROMET
  • 7.5 mgtablet CombinationErtugliflozin Pidolate 7.5 mg + Metformin 500 mgSEGLUROMET
  • 5 mgtablet CombinationErtugliflozin Pidolate 5 mg + Sitagliptin 100 mgSTEGLUJAN
  • 2.5 mgtablet CombinationErtugliflozin Pidolate 2.5 mg + Metformin 1,000 mgSEGLUROMET
Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型 其餘規格 1 個 · 涉及 1 種劑型
tablet · 12.5 mg

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.